Sculptra in Seoul

Sculptra is a collagen biostimulator, not a hyaluronic-acid filler. Unlike conventional fillers — which can sometimes look unnatural when overused — Sculptra works by triggering your own collagen regeneration over weeks, producing a more natural appearance. Sculptra and HA fillers are not injected at the same session, but they can be combined in a staged plan, with each layer placed at a different tissue depth and a clinical interval between sessions.

Sculptra is appropriate when the main goal is support and gradual collagen-focused change — typically for patients with early volume loss, cheek/temple deflation, or skin laxity that needs underlying scaffold rebuilding. Skin boosters (Rejuran, Skinvive, Profhilo) work on a different layer: they target hydration, fine texture, and skin quality without addressing volume or laxity. Many international patients receive both — Sculptra for structure plus a skin booster series for surface quality — over a 2-3 month staged plan.

Sculptra works gradually. Mild swelling lasts 24-72 hours, then a quiet period of 4-8 weeks before visible change begins as fibroblast-driven neocollagenesis activates. Peak results emerge at 3-6 months after the final session, when type I collagen remodeling is maximal. Durability is typically about 24 months after a full course, supported by the Narins 2010 randomized trial which documented sustained correction through 25 months (PMID 20159311). A maintenance session every ~2 years is typical.

Following injection, patients massage each treated area for 5 minutes, 5 times per day, for 5 days starting day 3. This protocol ensures even PLLA microparticle distribution in the dermis and substantially reduces nodule risk. Early low-dilution protocols in HIV facial lipoatrophy reported palpable — though non-visible — micronodules in up to 44% of patients (Valantin 2003); modern high-dilution reconstitution (8-9 mL per vial (face) / 16 mL per vial (body)) combined with the 5-5-5 rule and adequate hydration time markedly lowers that risk. Skipping the massage protocol is the single most common cause of palpable nodules.

Good candidates are typically patients aged 35-65 with early-to-moderate facial volume loss (cheek deflation, temple hollowing, jawline support) who prefer gradual natural change over a one-session transformation. Sculptra is NOT appropriate for lips or directly under the eyes. Contraindications include active skin infection in the area, autoimmune connective-tissue disease, keloid-prone skin, pregnancy or lactation, and known hypersensitivity to PLLA or lidocaine. Patients on rapid weight-loss medications (GLP-1 agonists like Ozempic) are often excellent candidates because Sculptra's original FDA indication was HIV-associated facial fat loss — analogous deflation pattern, well-studied response (Carey 2009 HIV Medicine 48-week follow-up, PMID 19245538).

HA filler typically lasts 9-18 months depending on the product and site; Sculptra's collagen scaffold persists for approximately 24 months after a full course. Over a 2-year window, HA filler patients typically have 1-2 top-up sessions while Sculptra patients complete the initial 3-session course and a single maintenance session at ~24 months. Per-session cost is similar, but the per-month equivalent often favors Sculptra for patients prioritizing longevity over reversibility. We discuss the full 24-month cost projection during consultation rather than quoting a single-session price out of context.

A typical international Sculptra patient plans either (a) the first session during a Seoul trip with subsequent sessions back home if their local dermatologist offers the protocol, or (b) two visits to Seoul approximately 4-6 weeks apart, with the final session either locally or on a third trip. Per visit, plan one consultation day + one treatment day + one downtime day (3 days minimum). Patients with one short trip available will hear an honest recommendation that Sculptra may not be the best fit and that a different category (HA filler for immediate visible change, or a skin booster series with home-care continuation) may serve them better. We do not push Sculptra onto patients whose travel timing doesn't support it.